Patient Demographics1
(N=1301)
- Patient demographics were generally comparable across regions1
Patient Treatment History1
(N=1301)
- Patient treatment history was broadly similar across regions1
Reference
- Ailawadhi S, Biru Y, Clavreul S, et al. Perspectives of healthcare providers and patients with relapsed/refractory multiple myeloma on treatment priorities and novel therapies. Patient Prefer Adherence.
2025;19:1089-1104. Published April 2, 2025. Taylor & Francis Ltd. Reprinted by permission of the publisher Informa UK Limited trading as Taylor & Francis Ltd, http://www.tandfonline.com